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Abstract 
Expression of the act-2 gene was studied in mouse tissues and during in vitro differentiation of embryocarcinoma PCC4, mouse neuroblastoma 
Neuro2A and NB4lA3 cells in the presence of retinoic acid (RA) or 1% DMSO. act-2 mRNA is characterized by a complex pattern and exists in 
both poly(A)’ and poly(A)- forms. act-2 mRNA was found in many cell lines, whereas Ott-2 protein was detected only in some of these cells. act-2 
expression also changed during cell differentiation. The cell differentiation is likely to be controlled not only at the gene transcription level, but also 
at the level of regulation of nuclear transcription factor activity. Such a regulatory mechanism would provide for a finer regulation of cell 
differentiation. 
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1. Introduction 
About ten proteins have been identified that bind to 
the octamer sequence (ATTTGCAT) by gel retardation 
assay. cDNAs for some of these proteins were obtained 
and sequenced [l-lo]. 
Analysis of act expression during mammalian onto- 
genesis has shown that the Ott proteins are expressed in 
various tissues and organs during both embryogenesis 
and the postnatal period. Their expression appears at 
very early stages of embryogenesis [l l-l 51. 
In order to determine whether the expression of active 
Ott-2 protein and act-2 mRNA depends on the stage of 
cell differentiation, we have chosen as a model system the 
in vitro differentiation of two neuroblastoma cell lines, 
NB41A3 (blasts) and Neuro2A (more differentiated cells 
with well-defined axons and dendrites), as well as the 
embryonic carcinoma PCC4 cell line. Retinoic acid (RA) 
and DMSO were used as the differentiation inducers. 
RA was shown to be an endogenous inducer of differen- 
tiation. Its influence on the genome is mediated by nu- 
clear receptors whereas the target of DMSO is still un- 
known [16]. 
It is known that differentiation of neuroblastoma cells 
to more mature neuron precursors is induced by cultiva- 
tion in the presence of 1% DMSO. Differentiation of 
PCC4 embryonic carcinoma cells caused by 1% DMSO 
*Corresponding author. Fax: (7) (095) 135 14 05 
results in derivatives of all three embryo sheet leaves. RA 
stimulates differentiation of PCC4 cells mainly to the 
neuron precursors [161. 
2. Materials and methods 
2.1. The m vitro induction of differentiation 
The induction of differentiation was carried out as described [16]. 
Two different ways of induction were used: cultivation for 6 days in the 
presence of 250 nM RA or 1% DMSO. 
2.2. DNA probe 
A double-stranded oligonucleotide, containing the octa-sequence, 
was used as a probe for protein binding (OCTA-26): CCGGAAGCT- 
GATTTGCATGTGCTGCC. 
2.3. Preparation of whole-cell extracts 
The lysates were prepared according to the earlier described scheme 
[171. 
2.4. Gel retardation assay 
Gel retardation assay was performed as described previously [18]. 
2.5. Preparation of total and poly(A)+ RNA 
This was carried out using 5 M guanidine thiocyanate as described 
previously [19]. Poly(A)+ was obtained from oligo(dT) columns. 
2.6. Preparation of cryohistoblots from the mouse embryos 
The day of the vaginal plug appearance was taken as the zero day 
of pregnancy. The cryohistoblots were obtained as described previously 
WI. 
2.7. Northern blot hybridization and hybridization of cryohistoblots 
Earlier we obtained act-2 cDNA [21] which was used for the prepara- 
tion of a “P-labeled RNA probe. The probe corresponds to the Pst- 
Sma fragment of act-2 cDNA, and does not contain POU box. The 
Pst-Sma fragment of the act-2 gene 1s not highly homologous to other 
POU genes. 
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3. Results and discussion 
The Northern blot hybridization of the myeloma NSI 
0 cell RNA with the RNA probe revealed act-2 mRNAs 
of 13,8,6, 3.6 and 2.3 kb (Figs. 1 and 2A). act-2 mRNA 
is present in the NS/O cells in both the poly(A)’ and the 
poly(A)- fractions. Only poly(A)’ RNA is present as 13 
and 8 kb transcripts (Fig. 2). The gel retardation assay 
identified active Ott-2 protein in the myeloma NS/O cell 
line (Fig. 3A). 
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The act-2 RNA probe hybridization with RNA from 
Balb/c mice tissues, followed by RNase A treatment, 
demonstrated the presence of act-2 mRNA in brain 
(transcripts 8 and 2.3 kb in poly(A)’ RNA and addi- 
tional bands of 1.7 and 1.3 kb in total brain RNA). The 
high molecular weight act-2 mRNA was not found in 
liver but present were act-2 mRNA transcripts of 2.3, 1.5 
and 1.3 kb. Transcripts of 2.3, 1.7 and 1.3 kb were found 
in kidney. Mainly mRNA of 1.3 kb was observed in 
poly(A)’ RNA from kidney (Fig. 1). 
Ftg. 1. Northern blot hybridization of RNA from the mouse myeloma 
cell line, NS/O, and from mouse Balb/c tissues. Hybridization was 
carried out with the “P-labeled RNA probe. The positions of markers 
are shown on the left. 
Northern blot hybridization of the same RNA probe 
with RNA from in vitro-differentiated and undifferenti- 
ated cell lines of embryocarcinoma PCC4, neuroblasto- 
mas NB41A3 and Neuro2A revealed the expression pat- 
tern of the act-2 gene (Fig. 2). 
used, dedifferentiation of Neuro2A cells begins, because 
RA causes some alterations in cellular morphology and 
the cells resemble neuroblasts. 
We have shown that active Ott-2 proteins are present 
in low numbers in the differentiated neuroblastoma cell 
line. NB41A3 and five bands of act-2 mRNA (13, 6, 1.9, 
1.7 and 1.3 kb) were detected in these cells. After DMSO 
treatment all the RNA bands were detected but Ott-2 
protein disappeared (Fig. 3A). 
Both Ott-2 protein and act-2 mRNA are absent in 
undifferentiated embryocarcinoma PCC4 cells. The dif- 
ferentiation caused by both RA and DMSO leads to the 
appearance of act-2 mRNA transcripts (6, 2.3, 1.9, 1.7 
and 1.3 kb) (Fig. 2B) and active Ott-2 protein (Fig. 3B). 
In the more differentiated Neuro2A cell line, active 
Ott-2 protein is present in very low amounts. Six act-2 
mRNA bands (13, 6. 2.3, 1.9, 1.7 and 1.3 kb) were de- 
tected in these cells. After DMSO treatment he amount 
of Ott-2 protein remained unaffected (Fig. 3A). RA 
caused a significant decrease in the 13 kb transcript (Fig. 
2B) and stimulated the expression of Ott-2 and Ott-1 
proteins. Evidently, under the experimental conditions 
The 4.5 kb band is characteristic of all cell types. We 
assume that this is due to cross-hybridization with ribo- 
somal 28 S RNA, because act-2 RNA and ribosomal 
28 S RNA contain extended GC-rich regions in which an 
essential homology is observed. 
To find out what level of the act-2 mRNA expression 
in the above-described ifferentiation systems in vitro 
corresponds to those proceeding during differentiation 
in vivo, we have carried out a series of hybridizations on 
mouse embryo histoblots, beginning from the sixth day 
of embryonic development to the third postnatal day. At 
day 6 (this stage corresponds to undifferentiated PCC4 
NB41A3 
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Fig. 2. Northern blot hybridization of RNA from undifferentiated and in vitro-differentiated cell lines (A,B). Cell lines are indicated above the picture. 
D, undifferentiated cells; DMSO, DMSO-induced differentiation; RA, RA-induced differentiation. To check the purity of poly(A)- RNA, the filter 
was hybridized with a foreign cDNA probe obtained from MS/O cells (C). 
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Fig. 3. Gel retardation assay with the octanucleotide probe, OCTA-26. Cell lines are indicated above the picture. The observed complexes are named 
according to the nomenclature of Scholer [30]. 
cells), the act-2 RNA expression was not observed on 
histoblots: it was first detected on day 8. On day 10 a 
strong hybridization in the neural tube was observed 
(data not shown) and on days 14-17 a very powerful 
expression was found in central nervous system, as well 
e17 
PI. 
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s. * 
Fig. 4. Expression of act-2 mRNA in embryonic and mature mouse 
tissues. Hybridization on cryohistoblots of embryos and newborn Balbl 
c mice at the stages: e17, embryonal day 17; 1st day, postnatal day 1; 
3rd day, postnatal day 3; pl., placenta; l., liver; s., spinal cord. 
as in liver and placenta (Fig. 4). On postnatal day 1 a 
decrease in act-2 expression begins in central nervous 
system and liver and on postnatal day 3 it disappears in 
spinal cord in the tail-to-head direction. By this time the 
differentiation of neurons is over. 
This analysis of 0~2-2 RNA has revealed a very com- 
plicated expression pattern in various cells and the exis- 
tence of a large number of hybridization bands. From 1 
to 5 act-2 mRNA bands were found in different cells: 
such a variety may be the result of alternative splicing 
[ 14,221. Our results show that there must be an additional 
mechanism of formation of a different molecular weight 
RNA which involves the specific splitting-off of the 
poly(A)’ terminus since we found act-2 mRNA in both 
poly(A)’ and poly(A)- fractions. 
In all the cell lines studied here, 0~2-2 mRNA was 
present at various stages of differentiation, whereas Oct- 
2 protein was found only at some stages of differentia- 
tion. This may be due to different reasons. First, the 
Ott-2 protein may exist in the cell in an inactive form, 
incapable of binding DNA, and, second, there may be a 
block at the translation level. We suggest hat there may 
be an intracellular mechanism regulating Ott-2 protein 
activity which allows the quick transformation of active 
Ott-2 protein into its inactive form. The differentiation 
is likely to be accompanied by both a complete inactiva- 
tion of the gene and by a simple inactivation of the 
protein nuclear transcription factor itself. Such a mecha- 
nism would provide for a finer regulation of cell differen- 
tiation without making it irreversible at each stage. 
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